ELMO2 Antikörper
-
- Target Alle ELMO2 Antikörper anzeigen
- ELMO2 (Engulfment and Cell Motility 2 (ELMO2))
- Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ELMO2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Aufreinigung
- Immunogen affinity purified
- Reinheit
- ≥95 % as determined by SDS-PAGE
- Immunogen
- engulfment and cell motility 2
- Isotyp
- IgG
- Top Product
- Discover our top product ELMO2 Primärantikörper
-
-
- Applikationshinweise
- WB: 1:500-1:2000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
- Haltbarkeit
- 12 months
-
- Target
- ELMO2 (Engulfment and Cell Motility 2 (ELMO2))
- Andere Bezeichnung
- ELMO2 (ELMO2 Produkte)
- Hintergrund
- Synonyms:CED12A, KIAA1834 Background:Involved in cytoskeletal rearrangements required for phagocytosis of apoptotic cells and cell motility. Acts in assocation with DOCK1 and CRK. Was initially proposed to be required in complex with DOCK1 to activate Rac Rho small GTPases. May enhance the guanine nucleotide exchange factor(GEF) activity of DOCK1.
- Molekulargewicht
- 83 kDa
- Gen-ID
- 63916
- UniProt
- Q96JJ3
-